Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy.
Vähä-Koskela M, Tähtinen S, Grönberg-Vähä-Koskela S, Taipale K, Saha D, Merisalo-Soikkeli M, Ahonen M, Rouvinen-Lagerström N, Hirvinen M, Veckman V, Matikainen S, Zhao F, Pakarinen P, Salo J, Kanerva A, Cerullo V, Hemminki A. Vähä-Koskela M, et al. Among authors: merisalo soikkeli m. Mol Ther Oncolytics. 2015 Jan 7;1:14006. doi: 10.1038/mto.2014.6. eCollection 2015. Mol Ther Oncolytics. 2015. PMID: 27119097 Free PMC article.
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.
Bramante S, Koski A, Kipar A, Diaconu I, Liikanen I, Hemminki O, Vassilev L, Parviainen S, Cerullo V, Pesonen SK, Oksanen M, Heiskanen R, Rouvinen-Lagerström N, Merisalo-Soikkeli M, Hakonen T, Joensuu T, Kanerva A, Pesonen S, Hemminki A. Bramante S, et al. Among authors: merisalo soikkeli m. Int J Cancer. 2014 Aug 1;135(3):720-30. doi: 10.1002/ijc.28696. Epub 2014 Jan 10. Int J Cancer. 2014. PMID: 24374597 Free article.
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.
Liikanen I, Koski A, Merisalo-Soikkeli M, Hemminki O, Oksanen M, Kairemo K, Joensuu T, Kanerva A, Hemminki A. Liikanen I, et al. Among authors: merisalo soikkeli m. Oncoimmunology. 2015 Apr 2;4(3):e989771. doi: 10.4161/2162402X.2014.989771. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949903 Free PMC article.
Oncolytic virotherapy trials--letter.
Hemminki A, Oksanen M, Merisalo-Soikkeli M. Hemminki A, et al. Among authors: merisalo soikkeli m. Clin Cancer Res. 2013 Aug 15;19(16):4541-2. doi: 10.1158/1078-0432.CCR-13-1471. Clin Cancer Res. 2013. PMID: 23946419 No abstract available.